Maravai Lifesciences Holdings (MRVI) Minority Interest (2020 - 2026)

Maravai Lifesciences Holdings' Minority Interest history runs 7 years deep, the most recent figure standing at $157.5 million for Q1 2026.

• In Q1 2026, Minority Interest fell 31.41% year-over-year to $157.5 million; the TTM figure through Mar 2026 stood at $157.5 million (down 31.41% YoY), while the FY2025 annual figure was $160.3 million, down 36.36% from the prior year.
• Minority Interest was $157.5 million for Q1 2026 at Maravai Lifesciences Holdings, down from $160.3 million in the prior quarter.
• In the past five years, Minority Interest ranged from a high of $379.1 million in Q1 2023 to a low of $157.5 million in Q1 2026.
• Historically, Minority Interest has averaged $291.1 million across 5 years, with a median of $317.2 million in 2022.
• The sharpest annual moves came in 2022 and 2025: Minority Interest soared 172.6% in 2022, then sank 40.16% in 2025.
• A 5-year view of Minority Interest shows it stood at $360.0 million in 2022, then increased by 3.64% to $373.1 million in 2023, then sank by 32.49% to $251.9 million in 2024, then tumbled by 36.36% to $160.3 million in 2025, then fell by 1.75% to $157.5 million in 2026.
• The last three Minority Interest figures came in at $157.5 million (Q1 2026), $160.3 million (Q4 2025), and $186.4 million (Q3 2025), per Business Quant data.